• 1
    Morris J, Shay D, Hebden J et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995; 123: 250259.
  • 2
    Davis J, Huycke M, Wells C et al. Surgical Infection Society position paper on vancomycin-resistant Enterococcus. Arch Surg 1996; 131: 10611068.
  • 3
    Papanicolaou G, Meyers B, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in transplant recipients: risk factors for acquisition and morbidity. Clin Infect Dis 1996; 23: 760766.
  • 4
    Patel R, Allen S, Manahan J et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7: 2731.
  • 5
    Green M, Barbadora K, Michaels M. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Micro 1991; 29: 25032506.
  • 6
    Newell K, Millis J, Arnow P et al. Incidence and outcome of infection by vancomycin-resistant enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439442.
  • 7
    Orloff S, Busch A, Olyaei A et al. Vancomycin-resistant enterococcus in liver transplant patients. Am J Surg 1999; 177: 418422.
  • 8
    Donskey C, Chowdry T, Hecker M et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 19251932.
  • 9
    Lautenbach E, Bilker W, Brennan P. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999; 20: 318323.
  • 10
    Ostrowsky B, Trick W, Sohn A et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001; 344: 14271433.
  • 11
    Tornieporth N, Roberts R, Hafner J, Riley L. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767772.
  • 13
    Rolachon A, Cordier L, Bacq Y, Nousbaum J. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995; 22: 11711174.
  • 15
    Gimes P, Rimola A, Planas R et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo controlled trial. Hepatology 1990; 12: 716724.
  • 16
    Campillo B, Dupeyron C, Richardet J et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998; 26: 10661070.
  • 17
    Kamath P, Wiesner R, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 18
    D'Agata E, Gautam S, Green W, Tang Y. Sensitivity of rectal swab for VRE. Clin Infect Dis 2002; 34: 167172.